ASPIRIN IN THE PREVENTION OF COLORECTAL-CANCER

被引:11
作者
GAREWAL, HS
机构
关键词
D O I
10.7326/0003-4819-121-4-199408150-00013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:303 / 304
页数:2
相关论文
共 25 条
[1]  
BORLING CC, 1993, CA-CANCER J CLIN, V43, P7
[2]   RENAL SYNDROMES ASSOCIATED WITH NONSTEROIDAL ANTIINFLAMMATORY DRUGS [J].
CLIVE, DM ;
STOFF, JS .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (09) :563-572
[3]  
DALEN JE, 1992, CHEST, V102, pS303
[4]   LOW-DOSE ASPIRIN AND INCIDENCE OF COLORECTAL TUMORS IN A RANDOMIZED TRIAL [J].
GANN, PH ;
MANSON, JE ;
GLYNN, RJ ;
BURING, JE ;
HENNEKENS, CH .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (15) :1220-1224
[5]   TREATMENT OF COLONIC AND RECTAL ADENOMAS WITH SULINDAC IN FAMILIAL ADENOMATOUS POLYPOSIS [J].
GIARDIELLO, FM ;
HAMILTON, SR ;
KRUSH, AJ ;
PIANTADOSI, S ;
HYLIND, LM ;
CELANO, P ;
BOOKER, SV ;
ROBINSON, CR ;
OFFERHAUS, GJA .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (18) :1313-1316
[6]   ASPIRIN USE AND THE RISK FOR COLORECTAL-CANCER AND ADENOMA IN MALE HEALTH-PROFESSIONALS [J].
GIOVANNUCCI, E ;
RIMM, EB ;
STAMPFER, MJ ;
COLDITZ, GA ;
ASCHERIO, A ;
WILLETT, WC .
ANNALS OF INTERNAL MEDICINE, 1994, 121 (04) :241-246
[7]   Colorectal cancer risk, chronic illnesses, operations and medications: case-control results from the Melbourne Colorectal Cancer Study (Reprinted from Cancer Research, vol 48, pg 4399-404, 1988) [J].
Kune, Gabriel A. ;
Kune, Susan ;
Watson, Lyndsey F. .
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2007, 36 (05) :951-957
[8]   COLON-CANCER SCREENING - BEYOND EFFICACY [J].
LIEBERMAN, D .
GASTROENTEROLOGY, 1994, 106 (03) :803-807
[9]   REDUCING MORTALITY FROM COLORECTAL-CANCER BY SCREENING FOR FECAL OCCULT BLOOD [J].
MANDEL, JS ;
BOND, JH ;
CHURCH, TR ;
SNOVER, DC ;
BRADLEY, GM ;
SCHUMAN, LM ;
EDERER, F .
NEW ENGLAND JOURNAL OF MEDICINE, 1993, 328 (19) :1365-1371
[10]   ASPIRIN USE AND CHRONIC DISEASES - A COHORT STUDY OF THE ELDERLY [J].
PAGANINIHILL, A ;
CHAO, A ;
ROSS, RK ;
HENDERSON, BE .
BRITISH MEDICAL JOURNAL, 1989, 299 (6710) :1247-1250